About Jonathan Yeh
Form D filings for RYNE Biotechnology from 2022 to 2024 list Jonathan Yeh as director.
Jonathan Yeh first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Yeh in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Yeh works with at each company, as listed on that company's latest Form D.
RYNE Biotechnology Inc. · Form D, Mar 1, 2024
JG
Jeff Goater
Director
PF
Peter Fuhrken
Director
HF
Howard Federoff
Executive officer and director
NM
Nick Manusos
CEO and director
DF
David Fallace
Director
JJ
Jeff Jonas
Director
MO
Martin Ostrowski
Executive officer